与衰老相关的LncRNAs:卵巢癌结果的开创性指标
Shao-Bei Fan1, Xiao-Feng Xie1, Wang Wei2
1Department of Gynecology, Affiliated Xingtai People Hospital of Hebei Medical University, 16 Hongxing Road, Xingtai, Hebei 054001 People's Republic of China.
Phenomics (Cham, Switzerland)
|November 25, 2024
概括
这项研究确定了与衰老相关的长非编码RNA (SnRlncRNAs) 作为卵巢癌 (OC) 的关键预后生物标志物. 开发的风险特征为患者的结果和治疗反应提供了卓越的预测准确性.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 卵巢癌 (OC) 是最致命的妇科恶性瘤,需要改进的预后工具.
- 长非编码RNAs (lncRNAs),特别是与衰老相关的lncRNAs (SnRlncRNAs),在OC进展和预后中发挥着关键作用.
研究的目的:
- 为了识别和验证SnRlncRNAs作为卵巢癌的预后生物标志物.
- 开发一个强大的风险特征来预测OC患者的结果和治疗反应.
主要方法:
- 使用GTEx和TCGA数据集来识别SnRlncRNAs.
- 使用共同表达,差异表达,考克斯回归和LASSO构建了一个风险特征.
- 使用依赖时间的ROC,多变量考克斯回归和ICGC数据验证了签名.
- 进行了GSEA和共识聚类,用于途径和子组分析.
主要成果:
- 一个经过验证的风险标志显示出强大的预测准确性,超过了传统的临床指标 (阶段,等级).
- 低风险患者表现出增加的免疫透和差异性的药物敏感性.
- 共识聚类确定了四个不同的患者子组,根据17个SnRlncRNAs的不同生存率.
结论:
- 开发的基于SnRlncRNA的风险特征是卵巢癌的可靠预后工具.
- 这些生物标志物为改善临床决策,风险分层和预测抗癌疗法的反应提供了潜力.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K


